当前位置：首页 > 文献互助 > 互助详情

In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia复制

MOMO 8分钟前 8 10 求助中 帖子自动结束时间: 2026-05-31 12:08:18

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1056/NEJMoa2601283复制

文献链接: http://www.nejm.org/doi/10.1056/NEJMoa2601283复制

其他信息:

出版社: Massachusetts Medical Society
作者: Scott B. Vafai; Jörg Täubel; Thomas Ashdown; Riyaz S. Patel; Sadaf Diamondali; Jaimini Cegla; Handrean Soran; Bilal Bashir; Alexander Abitbol; Daniel Gaudet; Alex Lauzière; Liam R. Brunham; David E. Newby; Stephen J. Nicholls; Russell S. Scott; Jane Kerr; Jean-Claude Tardif; Catherine Lunken; Steve E. Humphries; Verena Karsten; Patrick D. Tyler; Xinyan Zhang; Nidal Huniti; Patrick A. Flight; Chelsey L. Jensen; Rick Falzone; Joseph C. Biedenkapp; Troy Lister; Leslie E. Stolz; Amit V. Khera; Sekar Kathiresan

上一篇：Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors

下一篇：附件附件求附件！！In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia

互助时间线

2026-05-26 12:08:18 [发起求助]

最新发布的求助

附件附件求附件！！In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia 5分钟前
In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia 8分钟前
Vascular Normalization Augments the Antitumor Efficacy of Combined HDAC Inhibitor with Immunotherapy in Solid Tumors 12分钟前
Selective and Potent Molecular Glue Degraders for NIMA-Related Kinase 7 13分钟前
Silylated Melamine and Cyanuric Acid as Precursors for Imprinted and Hybrid Silica Materials with Molecular Recognition Properties 24分钟前
Hydrophilic nano-SiO2/PVA-based coating with durable antifogging properties 47分钟前
Trial of the Oral PCSK9 Inhibitor Enlicitide. Reply 55分钟前
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2026 American College of Cardiology Conference 57分钟前
Oral epinastine vs loratadine in seasonal allergic rhinitis: A randomized, double‑blind, placebo‑controlled trial 59分钟前
Mining of adverse event signals associated with inclisiran: a post-marketing analysis based on FAERS 1小时前
Phase 3 study results for oral PCSK9 inhibition with enlicitide 1小时前
Epinastine: An update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases. 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com